RNS
CLVS

Robert N. Shapiro’s Clovis Oncology, Inc. CLVS Stock Holding History

Robert N. Shapiro’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$131K Hold
2,333
– – 0.03% 312
2014
Q3 		$106K Hold
2,333
– – 0.02% 369
2014
Q2 		$97K Hold
2,333
– – 0.02% 377
2014
Q1 		$162K Hold
2,333
– – 0.03% 296
2013
Q4 		$141K Hold
2,333
– – 0.03% 320
2013
Q3 		$142K Buy
+2,333
New +$165K 0.03% 330

Other funds holding CLVS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Robert N. Shapiro's CLVS Position: Q4 2014 in Review

Robert N. Shapiro held its Clovis Oncology, Inc. (CLVS) position steady in Q4 2014 at 2,333 shares worth $131K. The position accounts for 0.03% of the portfolio, ranked #312.

Robert N. Shapiro first reported a position in CLVS in Q3 2013 and has held it in 6 quarters since. The position peaked at $162K in Q1 2014. 143 funds tracked by Wall St. Rank hold CLVS as of Q4 2014.

  • Robert N. Shapiro held 2,333 shares of Clovis Oncology, Inc. worth $131K as of Q4 2014.
  • Robert N. Shapiro left its Clovis Oncology, Inc. share count unchanged in Q4 2014.
  • Clovis Oncology, Inc. made up 0.03% of Robert N. Shapiro's portfolio in Q4 2014, its #312 holding.
  • Robert N. Shapiro first reported a position in Clovis Oncology, Inc. in Q3 2013 and has held it in 6 quarters since.
  • Robert N. Shapiro's Clovis Oncology, Inc. position peaked at $162K in Q1 2014.
  • 143 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2014.

Based on Robert N. Shapiro's 13F filing for Q4 2014, filed 19 Feb 2015.